BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24211327)

  • 1. In silico simulations of STAT1 and STAT3 inhibitors predict SH2 domain cross-binding specificity.
    Szelag M; Sikorski K; Czerwoniec A; Szatkowska K; Wesoly J; Bluyssen HA
    Eur J Pharmacol; 2013 Nov; 720(1-3):38-48. PubMed ID: 24211327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
    Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA
    PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of IFN-alpha signals.
    Gupta S; Yan H; Wong LH; Ralph S; Krolewski J; Schindler C
    EMBO J; 1996 Mar; 15(5):1075-84. PubMed ID: 8605877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization.
    Schust J; Sperl B; Hollis A; Mayer TU; Berg T
    Chem Biol; 2006 Nov; 13(11):1235-42. PubMed ID: 17114005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative screening and validation as a novel tool to identify STAT-specific inhibitors.
    Szeląg M; Czerwoniec A; Wesoly J; Bluyssen HA
    Eur J Pharmacol; 2014 Oct; 740():417-20. PubMed ID: 25183399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs.
    Plens-Galaska M; Szelag M; Collado A; Marques P; Vallejo S; Ramos-González M; Wesoly J; Sanz MJ; Peiró C; Bluyssen HAR
    Front Immunol; 2018; 9():2141. PubMed ID: 30283459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
    Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
    Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing.
    Tadlaoui Hbibi A; Laguillier C; Souissi I; Lesage D; Le Coquil S; Cao A; Metelev V; Baran-Marszak F; Fagard R
    FEBS J; 2009 May; 276(9):2505-15. PubMed ID: 19476491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes.
    Krejci P; Salazar L; Goodridge HS; Kashiwada TA; Schibler MJ; Jelinkova P; Thompson LM; Wilcox WR
    J Cell Sci; 2008 Feb; 121(Pt 3):272-81. PubMed ID: 18198189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Inhibition of STAT3 with Respect to STAT1: Insights from Molecular Dynamics and Ensemble Docking Simulations.
    Yesylevskyy SO; Ramseyer C; Pudlo M; Pallandre JR; Borg C
    J Chem Inf Model; 2016 Aug; 56(8):1588-96. PubMed ID: 27479469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring dual inhibitors for STAT1 and STAT5 receptors utilizing virtual screening and dynamics simulation validation.
    Raj U; Kumar H; Gupta S; Varadwaj PK
    J Biomol Struct Dyn; 2016 Oct; 34(10):2115-29. PubMed ID: 26471877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. II. Src homology SH2 domains define the specificity of stat factor activation.
    Hemmann U; Gerhartz C; Heesel B; Sasse J; Kurapkat G; Grötzinger J; Wollmer A; Zhong Z; Darnell JE; Graeve L; Heinrich PC; Horn F
    J Biol Chem; 1996 May; 271(22):12999-3007. PubMed ID: 8662795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of phosphopeptide motifs specific for the Src homology 2 domains of signal transducer and activator of transcription 1 (STAT1) and STAT3.
    Wiederkehr-Adam M; Ernst P; Müller K; Bieck E; Gombert FO; Ottl J; Graff P; Grossmüller F; Heim MH
    J Biol Chem; 2003 May; 278(18):16117-28. PubMed ID: 12591923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
    Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
    J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new small-molecule Stat3 inhibitor.
    McMurray JS
    Chem Biol; 2006 Nov; 13(11):1123-4. PubMed ID: 17113993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the binding of high affinity phosphopeptides to Stat3.
    McMurray JS
    Biopolymers; 2008; 90(1):69-79. PubMed ID: 18058821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dd-STATb, a Dictyostelium STAT protein with a highly aberrant SH2 domain, functions as a regulator of gene expression during growth and early development.
    Zhukovskaya NV; Fukuzawa M; Tsujioka M; Jermyn KA; Kawata T; Abe T; Zvelebil M; Williams JG
    Development; 2004 Jan; 131(2):447-58. PubMed ID: 14701681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mutation in the SH2 domain of STAT2 prolongs tyrosine phosphorylation of STAT1 and promotes type I IFN-induced apoptosis.
    Scarzello AJ; Romero-Weaver AL; Maher SG; Veenstra TD; Zhou M; Qin A; Donnelly RP; Sheikh F; Gamero AM
    Mol Biol Cell; 2007 Jul; 18(7):2455-62. PubMed ID: 17442890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T; Ma J; Cao X
    Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation.
    Stancato LF; David M; Carter-Su C; Larner AC; Pratt WB
    J Biol Chem; 1996 Feb; 271(8):4134-7. PubMed ID: 8626752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.